SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Concluded an Inspection of Apicore LLC’s API Manufacturing Plant in Somerset, NJ, USA with No Form 483 Citations

July 16, 2010 | 
1 min read
SOMERSET, N.J.--(BUSINESS WIRE)--Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its API manufacturing plant in Somerset, New Jersey on July 13, 2010.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
Prasad Out at FDA, Lawmaker Takes Action on Rare Disease Rejections and a Spate of Obesity Data
March 11, 2026
 · 
1 min read
 · 
Heather McKenzie
External view of the U.S. Capitol Building
Rare diseases
Senator Ron Johnson Launches Investigation Into FDA Rare Disease Rejections
March 10, 2026
 · 
3 min read
 · 
Heather McKenzie
FDA signage at its headquarters in Maryland
Manufacturing
FDA Sets Scope for Attempt To Reduce Manufacturing-Related Approval Rejections
March 10, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Flat 3d isometric business people came from different way but have same target. Business team and target concept.
Insights
Single Pivotal Trials Demand Stronger Data and Risk Strategies
March 10, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker